Results 281 to 289 of about 266,537 (289)

Preoperative Periapical Status and Outcomes of Vital Pulp Therapy: A Systematic Review and Meta‐Analysis

open access: yesAustralian Endodontic Journal, EarlyView.
ABSTRACT This systematic review has investigated whether the preoperative periapical radiographic status (PPRS) is a predictor of VPT success/survival. Four databases were searched for studies published from inception to November 2024. The studies' characteristics were tabulated, and a meta‐analysis was performed to evaluate the correlation between ...
Isadora de Souza Basso   +3 more
wiley   +1 more source

Demographic Factors Influencing Eligibility for EMA in South Australia

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Early medical abortion (EMA) can be performed by administration of mifepristone and misoprostol in an outpatient setting prior to 63 days gestation in Australia. While this is a flexible, efficacious and safe option for abortion, it requires early identification of pregnancy and efficient access to a clinical service. Outpatient EMA
Laura Slade   +3 more
wiley   +1 more source

The Sociodemographic Benefits of Extending MS‐2Step to 70 Days in Australia

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT In many areas of the world, outpatient early medical abortion (EMA) is provided through mifepristone and misoprostol up to 10 weeks or 70 days gestation; however in Australia access is restricted to 63 days. A retrospective cohort study using South Australian data from 2012 to 2020 compares women undergoing abortion at less than 9 weeks with ...
Laura Slade   +3 more
wiley   +1 more source

Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions

open access: yesAllergy, EarlyView.
ABSTRACT Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. The clinical presentation of AD is heterogeneous and is characterized by a relapsing and remitting course. Most patients suffer from mild AD while approximately 5% to 20% experience severe disease activity, which often requires systemic treatment ...
Marjolein S. de Bruin‐Weller   +9 more
wiley   +1 more source

Prostaglandin E<sub>2</sub>-EP2/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells. [PDF]

open access: yesNat Commun
Punyawatthananukool S   +16 more
europepmc   +1 more source

Influenza A virus selectively elevates prostaglandin E2 formation in pro-resolving macrophages. [PDF]

open access: yesiScience
Jordan PM   +6 more
europepmc   +1 more source

Platelet Immunoreactive Prostaglndin E and Plasma Immunoreactive Prostaglandin F2α in Pregnant Diabetics

open access: green, 1984
Masashi Honda   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy